Free Trial

Legend Biotech (LEGN) News Today

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)
Free LEGN Stock Alerts
$45.57
-0.99 (-2.13%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 7 at 7:28 AM | americanbankingnews.com
Legend Biotech Co. Expected to Post FY2025 Earnings of $0.02 Per Share (NASDAQ:LEGN)
June 7 at 6:17 AM | marketbeat.com
The Manufacturers Life Insurance Company Has $36.64 Million Position in Legend Biotech Co. (NASDAQ:LEGN)
The Manufacturers Life Insurance Company raised its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 3.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 608,995 shares of the company's stock
June 6 at 2:29 PM | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Shares Up 5.1%
Legend Biotech (NASDAQ:LEGN) Trading 5.1% Higher
June 5 at 3:56 AM | americanbankingnews.com
Legend Biotech's (LEGN) Buy Rating Reaffirmed at HC Wainwright
June 4, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Earns "Buy" Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $73.00 price objective on shares of Legend Biotech in a report on Tuesday.
June 4, 2024 | marketbeat.com
TD Asset Management Inc Lowers Holdings in Legend Biotech Co. (NASDAQ:LEGN)
TD Asset Management Inc lowered its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 12.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 238,216 shares of the company's stock after selling 33,344 shares during the quarter. TD Asse
June 3, 2024 | businesswire.com
Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA
June 3, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Reaches New 52-Week Low at $39.00
Legend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low at $39.00
June 3, 2024 | marketbeat.com
Hsbc Holdings PLC Purchases 148,985 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Hsbc Holdings PLC boosted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 312.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 196,715 shares of the company's stock after purchasing an additional 148
June 2, 2024 | marketbeat.com
Alberta Investment Management Corp Increases Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Alberta Investment Management Corp lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 413.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,160 shares of the company's stock after a
June 2, 2024 | americanbankingnews.com
Legend Biotech (NASDAQ:LEGN) Shares Down 6%
May 30, 2024 | marketbeat.com
Artisan Partners Limited Partnership Has $31.16 Million Position in Legend Biotech Co. (NASDAQ:LEGN)
Artisan Partners Limited Partnership lessened its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 517,837 shares of the c
May 29, 2024 | businesswire.com
Legend Biotech to Participate in the Jefferies Global Healthcare Conference
May 29, 2024 | americanbankingnews.com
Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Buy" from Analysts
May 29, 2024 | marketbeat.com
Legend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been assigned an average rating of "Buy" from the eleven analysts that are covering the company, MarketBeat reports. Eleven research analysts have rated the stock with a buy recommendation. The average 1-year price objective among a
May 28, 2024 | marketbeat.com
Trexquant Investment LP Purchases Shares of 25,949 Legend Biotech Co. (NASDAQ:LEGN)
Trexquant Investment LP purchased a new stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 25,949 shares of the company's stock, valued at approximately
May 26, 2024 | marketbeat.com
Westfield Capital Management Co. LP Purchases 108,097 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Westfield Capital Management Co. LP lifted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,776,247 shares of the co
May 26, 2024 | uk.investing.com
Legend Biotech stock PT cut by H.C. Wainwright amid revenue slowdown
May 24, 2024 | msn.com
Deutsche Bank Initiates Coverage of Legend Biotech Corporation - Depositary Receipt () (LEGN) with Buy Recommendation
May 23, 2024 | businesswire.com
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
May 23, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $40.31
Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low at $40.31
May 22, 2024 | finanznachrichten.de
MaxCyte, Inc: MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
May 21, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Trading Down 5.1%
Legend Biotech (NASDAQ:LEGN) Trading Down 5.1%
May 16, 2024 | marketbeat.com
Legend Biotech Co. (NASDAQ:LEGN) Stock Holdings Increased by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,984,826 shares of the company's stock after purchasing a
May 15, 2024 | marketbeat.com
First Turn Management LLC Purchases New Shares in Legend Biotech Co. (NASDAQ:LEGN)
First Turn Management LLC acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 476,079 shares of the company's stock, valued at approximat
May 15, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)
May 15, 2024 | msn.com
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript
May 14, 2024 | markets.businessinsider.com
Buy Rating for Legend Biotech Anchored by Carvykti’s Growth and Market Penetration Potential
May 14, 2024 | marketbeat.com
Nicholas Investment Partners LP Trims Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Nicholas Investment Partners LP reduced its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 26,650 shares of the company's stock after selling 566,360 shares during the period.
May 14, 2024 | markets.businessinsider.com
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
May 14, 2024 | marketbeat.com
Royal Bank of Canada Boosts Legend Biotech (NASDAQ:LEGN) Price Target to $86.00
Royal Bank of Canada lifted their price target on shares of Legend Biotech from $85.00 to $86.00 and gave the stock an "outperform" rating in a report on Tuesday.
May 14, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS
Legend Biotech (NASDAQ:LEGN - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.13. The business had revenue of $93.90 million during the quarter, compared to analyst estimates of $143.24 million. Legend Biotech had a negative net margin of 181.75% and a negative return on equity of 37.19%. The company's revenue for the quarter was up 158.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.40) EPS.
May 14, 2024 | seekingalpha.com
Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances
May 14, 2024 | finance.yahoo.com
Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...
May 14, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Legend Biotech on CARVYKTI Growth and Positive Clinical Developments
May 14, 2024 | finance.yahoo.com
Q1 2024 Legend Biotech Corp Earnings Call
May 13, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24
Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24
May 13, 2024 | marketwatch.com
Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales
May 13, 2024 | seekingalpha.com
Legend Biotech Corporation 2024 Q1 - Results - Earnings Call Presentation
May 13, 2024 | msn.com
Legend Biotech Vaults on Quarterlies
May 13, 2024 | businesswire.com
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
May 12, 2024 | marketbeat.com
Jump Financial LLC Buys 74,272 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Jump Financial LLC lifted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 157.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,481 shares of the company's stock after p
May 9, 2024 | marketbeat.com
TimesSquare Capital Management LLC Increases Position in Legend Biotech Co. (NASDAQ:LEGN)
TimesSquare Capital Management LLC lifted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,065,889 shares of the company's stock after buying an
May 9, 2024 | marketbeat.com
Legend Biotech's (LEGN) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $87.00 price target on shares of Legend Biotech in a report on Thursday.
April 30, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $43.92
Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low at $43.92
April 23, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $87.00 price objective on shares of Legend Biotech in a report on Tuesday.
April 23, 2024 | marketbeat.com
Sumitomo Mitsui Trust Holdings Inc. Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)
Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,130 shares of the company's stock after
April 23, 2024 | markets.businessinsider.com
Hold Rating on Legend Biotech Amidst Approval of Carvykti and Commercial Manufacturing Challenges
April 22, 2024 | businesswire.com
CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
April 22, 2024 | marketbeat.com
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $45.52
Legend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $45.52
Get Legend Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

LEGN Media Mentions By Week

LEGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LEGN
News Sentiment
▼
0.63

0.73
▲
Average
Medical
News Sentiment

LEGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LEGN Articles
This Week
▼
13

4
▲
LEGN Articles
Average Week

Get Legend Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:LEGN) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...
Crypto 101 Media | Sponsored